The present invention provides crude extracts from the red seaweeds: Polysiphonia lanosa (PL), Polysiphonia urceloata (PU), Cystoclonium purpureum (CP) and Devaleraea ramentacia (DR), method of preparation and their use for inhibiting the growth of microbial cells, particularly bacteria causing acne, such as Propionibacterium acnes, or causing nosocomial infections such as MRSA in humans or MRSP in dogs.

The invention relates to a pharmaceutical composition of an extract of Agarophyton chilensis, with antiproliferative effect in prostate cancer, comprising

(a) 0.1 to 90% of an oleoresin of Agarophyton chilensis, with the following major components: palmitic acid, arachidonic acid, oleic acid, stearic acid, meristic acid, linoleic acid; and

(b) 10 to 99.9% excipients and formulation aids for different pharmaceutical forms. And its use to prepare a drug for the treatment or prevention of prostate cancer and other hyperproliferative states of prostate tissue cells.

The invention relates to a pharmaceutical composition of an extract of Agarophyton chilensis, with antiproliferative effect in prostate cancer, comprising

(a) 0.1 to 90% of an oleoresin of Agarophyton chilensis, with the following major components: palmitic acid, arachidonic acid, oleic acid, stearic acid, meristic acid, linoleic acid; and

(b) 10 to 99.9% excipients and formulation aids for different pharmaceutical forms. And its use to prepare a drug for the treatment or prevention of prostate cancer and other hyperproliferative states of prostate tissue cells.

The field of the invention relates to processes for preparing Asparagopsis oil compositions, comprising extracting at least one bioactive from a biomass of Asparagopsis into an oil to form the compositions. These compositions are suitable for reducing total gas production and/or methane production in a ruminant or pseudo-ruminant animal.

The field of the invention relates to processes for preparing Asparagopsis oil compositions, comprising extracting at least one bioactive from a biomass of Asparagopsis into an oil to form the compositions. These compositions are suitable for reducing total gas production and/or methane production in a ruminant or pseudo-ruminant animal.

Formulations comprising a combination of red propolis and red algae, e.g., L. calcareum, as active ingredients, and methods of treatment using the same are provided herein. In various embodiments, the formulation may be in the form of, e.g., an aqueous solution or suspension, an ingestible solid or liquid form, or a topical preparation, and may be used to treat a variety of diseases and conditions responsive to the combination.

Formulations comprising a combination of red propolis and red algae, e.g., L. calcareum, as active ingredients, and methods of treatment using the same are provided herein. In various embodiments, the formulation may be in the form of, e.g., an aqueous solution or suspension, an ingestible solid or liquid form, or a topical preparation, and may be used to treat a variety of diseases and conditions responsive to the combination.

Formulations comprising a combination of red propolis and red algae, e.g., L. calcareum, as active ingredients, and methods of treatment using the same are provided herein. In various embodiments, the formulation may be in the form of, e.g., an aqueous solution or suspension, an ingestible solid or liquid form, or a topical preparation, and may be used to treat a variety of diseases and conditions responsive to the combination.

A medicament for use in treating hypertension. The medicament is a glycoprotein, a mixture of polysaccharide and protein, a polypeptide or a protein.

A medicament for use in treating hypertension. The medicament is a glycoprotein, a mixture of polysaccharide and protein, a polypeptide or a protein.